NO20061872L - Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav - Google Patents

Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav

Info

Publication number: NO20061872L
Authority: NO; Norway
Prior art keywords: disulfide; sulfoxide; sulfide; cyclic sugars; sulfo derivatives
Prior art date: 2003-10-03

Application number

NO20061872A

Other languages

English (en)

Norwegian (no)

Inventor

Jose Repolles Moliner

Eduardo Salas Perez-Rasilla

Francisco Pubill Coy

Original Assignee

Lacer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-03

Filing date

2006-04-27

Publication date

2006-06-30

2006-04-27 Application filed by Lacer Sa filed Critical Lacer Sa

2006-06-30 Publication of NO20061872L publication Critical patent/NO20061872L/no

Links

BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 title 1
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 title 1
235000000346 sugar Nutrition 0.000 title 1
150000008163 sugars Chemical class 0.000 title 1
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 title 1
150000003462 sulfoxides Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20061872A 2003-10-03 2006-04-27 Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav NO20061872L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200302368A ES2258365B1 (es)	2003-10-03	2003-10-03	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
PCT/EP2004/010882 WO2005037842A1 (en)	2003-10-03	2004-09-29	Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Publications (1)

Publication Number	Publication Date
NO20061872L true NO20061872L (no)	2006-06-30

Family

ID=34451643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061872A NO20061872L (no)	2003-10-03	2006-04-27	Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav

Country Status (34)

Country	Link
US (3)	US7521571B2 (de)
EP (1)	EP1668017B1 (de)
JP (2)	JP4809769B2 (de)
KR (1)	KR101141683B1 (de)
CN (1)	CN1863805B (de)
AP (1)	AP1976A (de)
AR (1)	AR045962A1 (de)
AT (1)	ATE423781T1 (de)
AU (1)	AU2004281916B2 (de)
BR (1)	BRPI0415020A (de)
CA (1)	CA2540500C (de)
DE (2)	DE112004001860T5 (de)
DK (1)	DK1668017T3 (de)
EA (1)	EA008942B1 (de)
EC (1)	ECSP066542A (de)
ES (2)	ES2258365B1 (de)
GB (1)	GB2421241B (de)
GE (1)	GEP20084490B (de)
GT (1)	GT200400200A (de)
HR (1)	HRP20090152T3 (de)
IL (1)	IL174371A0 (de)
IS (1)	IS8436A (de)
MX (1)	MXPA06003610A (de)
NO (1)	NO20061872L (de)
NZ (1)	NZ546043A (de)
PA (1)	PA8614201A1 (de)
PE (1)	PE20050436A1 (de)
PL (1)	PL1668017T3 (de)
PT (1)	PT1668017E (de)
RS (1)	RS20060241A (de)
SI (1)	SI1668017T1 (de)
UY (1)	UY28547A1 (de)
WO (1)	WO2005037842A1 (de)
ZA (1)	ZA200603475B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (de) *	2006-12-28	2008-07-09	Lacer, S.A.	Isosorbidmononitrit Derivate zur Behandlung von der Inflammation und okularen Hypertension
ES2332565B1 (es) *	2007-01-23	2010-10-21	Lacer, S.A.	Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios.
US20090111826A1 (en) *	2007-02-13	2009-04-30	Louis Lange	Use of ranolazine for the treatment of cardiovascular diseases
EP2117549A1 (de) *	2007-02-13	2009-11-18	CV Therapeutics Inc.	Verwendung von ranolazin zur behandlung koronarer mikrovaskulärer erkrankungen
JP2010518171A (ja) *	2007-02-13	2010-05-27	ギリアード・パロ・アルト・インコーポレイテッド	非冠微小血管疾患の処置のためのラノラジンの使用
CA2678272A1 (en) *	2007-02-13	2008-10-02	Cv Therapeutics, Inc.	Use of ranolazine for the treatment of cardiovascular diseases
WO2008116083A1 (en) *	2007-03-22	2008-09-25	Cv Therapeutics, Inc.	Use of ranolazine for elevated brain-type natriuretic peptide
CA2689633A1 (en) *	2007-05-31	2008-12-11	Cv Therapeutics, Inc.	Use of ranolazine for elevated brain-type natriuretic peptide
IE20070934A1 (en)	2007-12-21	2009-06-24	Trinity College Dublin	Efficient aspirin prodrugs
CA2706082C (en) *	2008-02-07	2017-10-03	Nicox S.A.	Nitric oxide donor compounds
EP2149577B1 (de) *	2008-07-22	2011-04-27	Lacer, S.A.	Neues stereospezifisches Verfahren zur Herstellung von Dioxabicyclooctan-Verbindungen
EP2149576A1 (de) *	2008-07-22	2010-02-03	Lacer, S.A.	Isosorbitnitrate mit vasodilatierender Wirksamkeit
EP2177216A1 (de) *	2008-10-13	2010-04-21	Lacer, S.A.	Verwendung von Dianhydrohexit-Mononitrat-Derivaten als Heilungsmittel
WO2010055138A1 (en) *	2008-11-14	2010-05-20	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (de)	2008-12-19	2010-06-23	Lacer, S.A.	Neues stereoskopisches Verfahren zur Herstellung von Dioxa-Bicyclooctan-Nitratverbindungen
ES2587191T3 (es) *	2009-12-23	2016-10-21	Arca Biopharma, Inc.	Métodos y composiciones para enfermedades y afecciones cardiovasculares
FR2977252B1 (fr) *	2011-06-30	2013-08-02	Seppic Sa	Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
JP6021938B2 (ja)	2011-12-16	2016-11-09	スリーエムイノベイティブプロパティズカンパニー	メルカプト含有ビスアンヒドロヘキシトール誘導体及びその使用
CA2902009A1 (en) *	2013-03-05	2014-09-12	Archer Daniels Midland Company	Isohexide monotriflates and process for synthesis thereof
CN116173012A (zh) *	2022-12-05	2023-05-30	温州医科大学	白当归脑在制备缺血性脑卒中神经保护用药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1356374A (en) *	1971-04-29	1974-06-12	American Home Prod	Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol
US3886186A (en)	1971-04-29	1975-05-27	American Home Prod	Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3102947A1 (de)	1981-01-29	1982-09-02	Heinrich Mack Nachf., 7918 Illertissen	Verfahren zur herstellung von isosorbid-5-nitrat
IT1204571B (it) *	1987-05-08	1989-03-10	Chiesi Farma Spa	Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
US4891373A (en) *	1988-11-23	1990-01-02	Pfizer Inc.	Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
FR2680173A1 (fr) *	1991-08-07	1993-02-12	Hoechst Lab	Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
DK0656881T3 (da) *	1992-07-30	1999-06-23	Cal Int Ltd	Ester og kombinationer af et organisk nitrat og et salicylat
DE4410997A1 (de) *	1994-03-30	1995-10-26	Isis Pharma Gmbh	Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
IL120531A (en) *	1997-03-26	2006-12-31	Yissum Res Dev Co	Nitric oxide donors and pharmaceutical compositions containing them
ES2142773B1 (es) *	1998-10-07	2001-01-01	Lacer Sa	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20020013483A1 (en)	2000-07-13	2002-01-31	Consortium Fur Elektrochemische Industrie Gmbh	Process for the preparation of dianhydrohexitol bisacylates
CA2421885A1 (en) *	2000-10-27	2002-05-02	Nitromed, Inc.	Methods of treating vascular diseases characterized by nitric oxide insufficiency
UA63467A (en)	2003-04-22	2004-01-15		Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

2003
- 2003-10-03 ES ES200302368A patent/ES2258365B1/es not_active Expired - Fee Related
2004
- 2004-09-29 ES ES04765682T patent/ES2322468T3/es not_active Expired - Lifetime
- 2004-09-29 KR KR1020067006283A patent/KR101141683B1/ko not_active Expired - Fee Related
- 2004-09-29 GE GEAP20049372A patent/GEP20084490B/en unknown
- 2004-09-29 BR BRPI0415020-1A patent/BRPI0415020A/pt not_active IP Right Cessation
- 2004-09-29 AU AU2004281916A patent/AU2004281916B2/en not_active Ceased
- 2004-09-29 CN CN2004800289355A patent/CN1863805B/zh not_active Expired - Fee Related
- 2004-09-29 SI SI200431109T patent/SI1668017T1/sl unknown
- 2004-09-29 PT PT04765682T patent/PT1668017E/pt unknown
- 2004-09-29 JP JP2006530042A patent/JP4809769B2/ja not_active Expired - Fee Related
- 2004-09-29 AT AT04765682T patent/ATE423781T1/de not_active IP Right Cessation
- 2004-09-29 WO PCT/EP2004/010882 patent/WO2005037842A1/en not_active Ceased
- 2004-09-29 DK DK04765682T patent/DK1668017T3/da active
- 2004-09-29 DE DE112004001860T patent/DE112004001860T5/de not_active Withdrawn
- 2004-09-29 AP AP2006003605A patent/AP1976A/xx active
- 2004-09-29 DE DE602004019666T patent/DE602004019666D1/de not_active Expired - Lifetime
- 2004-09-29 RS YUP-2006/0241A patent/RS20060241A/sr unknown
- 2004-09-29 PL PL04765682T patent/PL1668017T3/pl unknown
- 2004-09-29 US US10/544,237 patent/US7521571B2/en not_active Expired - Fee Related
- 2004-09-29 HR HR20090152T patent/HRP20090152T3/xx unknown
- 2004-09-29 GB GB0605574A patent/GB2421241B/en not_active Expired - Fee Related
- 2004-09-29 EA EA200600694A patent/EA008942B1/ru not_active IP Right Cessation
- 2004-09-29 NZ NZ546043A patent/NZ546043A/en unknown
- 2004-09-29 EP EP04765682A patent/EP1668017B1/de not_active Expired - Lifetime
- 2004-09-29 MX MXPA06003610A patent/MXPA06003610A/es active IP Right Grant
- 2004-09-29 CA CA2540500A patent/CA2540500C/en not_active Expired - Fee Related
- 2004-09-30 PE PE2004000957A patent/PE20050436A1/es not_active Application Discontinuation
- 2004-10-01 AR ARP040103576A patent/AR045962A1/es unknown
- 2004-10-01 UY UY28547A patent/UY28547A1/es not_active Application Discontinuation
- 2004-10-01 GT GT200400200A patent/GT200400200A/es unknown
- 2004-10-01 PA PA20048614201A patent/PA8614201A1/es unknown
2006
- 2006-03-16 IL IL174371A patent/IL174371A0/en unknown
- 2006-04-27 NO NO20061872A patent/NO20061872L/no not_active Application Discontinuation
- 2006-05-02 ZA ZA200603475A patent/ZA200603475B/xx unknown
- 2006-05-03 EC EC2006006542A patent/ECSP066542A/es unknown
- 2006-05-03 IS IS8436A patent/IS8436A/is unknown
2009
- 2009-03-09 US US12/400,394 patent/US7777058B2/en not_active Expired - Fee Related
2010
- 2010-04-06 US US12/755,103 patent/US8541607B2/en not_active Expired - Fee Related
- 2010-10-08 JP JP2010228789A patent/JP2011012081A/ja active Pending

Also Published As

Publication number	Publication date
US7777058B2 (en)	2010-08-17
IL174371A0 (en)	2006-08-01
BRPI0415020A (pt)	2006-11-07
EP1668017A1 (de)	2006-06-14
JP2011012081A (ja)	2011-01-20
HK1092807A1 (en)	2007-02-16
JP2007507451A (ja)	2007-03-29
CA2540500C (en)	2012-08-28
HRP20090152T3 (en)	2009-05-31
GB0605574D0 (en)	2006-04-26
EP1668017B1 (de)	2009-02-25
PE20050436A1 (es)	2005-06-23
AU2004281916A1 (en)	2005-04-28
US20100196387A1 (en)	2010-08-05
GB2421241B (en)	2008-04-16
RS20060241A (sr)	2008-06-05
DE112004001860T5 (de)	2006-07-27
KR101141683B1 (ko)	2012-05-07
CN1863805B (zh)	2010-06-16
EA200600694A1 (ru)	2006-10-27
US7521571B2 (en)	2009-04-21
US20090169560A1 (en)	2009-07-02
EA008942B1 (ru)	2007-10-26
MXPA06003610A (es)	2006-06-05
ES2258365A1 (es)	2006-08-16
AP2006003605A0 (en)	2006-04-30
JP4809769B2 (ja)	2011-11-09
ZA200603475B (en)	2007-09-26
GEP20084490B (en)	2008-09-25
GT200400200A (es)	2005-05-23
CA2540500A1 (en)	2005-04-28
AU2004281916B2 (en)	2010-10-21
DK1668017T3 (da)	2009-05-11
KR20060066743A (ko)	2006-06-16
AP1976A (en)	2009-03-16
ES2322468T3 (es)	2009-06-22
US8541607B2 (en)	2013-09-24
DE602004019666D1 (de)	2009-04-09
IS8436A (is)	2006-05-03
PA8614201A1 (es)	2005-05-24
GB2421241A (en)	2006-06-21
CN1863805A (zh)	2006-11-15
SI1668017T1 (sl)	2009-08-31
PT1668017E (pt)	2009-03-09
AR045962A1 (es)	2005-11-16
WO2005037842A1 (en)	2005-04-28
ECSP066542A (es)	2006-10-17
UY28547A1 (es)	2005-04-29
US20060235052A1 (en)	2006-10-19
PL1668017T3 (pl)	2009-07-31
ES2258365B1 (es)	2007-12-01
ATE423781T1 (de)	2009-03-15
NZ546043A (en)	2009-02-28

Legal Events

Date	Code	Title	Description
2011-05-09	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20080789L (no)	2008-02-13	1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
GB2421241A (en)	2006-06-21	Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
NO20091893L (no)	2009-07-09	Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20052493L (no)	2005-05-24	Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20050828L (no)	2005-04-05	lndol-3-svovelderivater
NO20052496L (no)	2005-06-24	Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20076018L (no)	2008-05-02	Lagringsstabile opplosninger av optiske hvitemidler
WO2007148185A3 (en)	2008-03-13	Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
EA200500203A1 (ru)	2005-08-25	Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
NO20076648L (no)	2008-03-17	Novel thiophene derivatives
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20092286L (no)	2009-08-13	Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20064032L (no)	2006-11-08	DPP-IV inhibitorer
CY1111481T1 (el)	2015-08-05	Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
NO20076478L (no)	2008-01-28	Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
CY1113267T1 (el)	2016-04-13	Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1
NO20090910L (no)	2009-03-24	Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister
AR039936A1 (es)	2005-03-09	Formulacion farmaceutica de liberacion modificada
NO20070089L (no)	2007-01-05	DPP-IV inhibitorer
GEP20115166B (en)	2011-02-25	2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
NO20054787D0 (no)	2005-10-18	Indenderivater som farmasotiske midler
NO20070974L (no)	2007-03-02	Substituerte N-acyl-2-aminotiazoler
WO2007017728A3 (en)	2008-04-03	Novel heterocyclic compounds
TW200800962A (en)	2008-01-01	Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
EA200801365A1 (ru)	2008-10-30	Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины